New COVID vaccine shows promise for all ages 3+
NCT ID NCT04869592
First seen Jan 18, 2026 · Last updated May 24, 2026 · Updated 21 times
Summary
This study tested a new COVID-19 vaccine made with CHO cells in 3,100 healthy people aged 3 and older. The goal was to see if the vaccine is safe and triggers a strong immune response. Participants received either the vaccine or a placebo in two doses. The trial is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ning ling Center for Disease Control and Prevention
Shangqiu, Henan, China
Conditions
Explore the condition pages connected to this study.